Jeremy Jones

Mr. Jeremy Jones


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JJJeremy Jones
Jeremy Jones
KFKyla Frenia
Kyla Frenia
KGKathleen Campbell Garwood
Kathleen Campbell Garwood
Kevin XiaoKevin Xiao
Kevin Xiao
Leanne T LabriolaLeanne T Labriola
Leanne T Labriola
Diabetes mellitus is a worldwide metabolic disorder that can be debilitating to many if uncontrolled. Biomarkers, such as hemoglobin A1C and glycated albumin, are central to the effort to control diabetes. These each have their own advantages and disadvantages, and there is much ongoing research into development of improved biomarkers and biomarker measurement methods. Continuous glucose monitoring is also widely used to closely monitor diabetes in patients today. Increasing, however, there has been research into use of biomarkers in alternative mediums, such as tear fluid or saliva. This review efficiently summarizes the current biomarkers used clinically today, their advantages and disadvantages, as well as the biomarkers on the horizon that could advance how diabetes is treated in the future.

Verified
Journal Article
Open access
PDF file
JJJeremy Jones
Jeremy Jones
KFKyla Frenia
Kyla Frenia
KGKathleen Campbell Garwood
Kathleen Campbell Garwood
Kevin XiaoKevin Xiao
Kevin Xiao
Leanne T LabriolaLeanne T Labriola
Leanne T Labriola
Diabetes mellitus is a worldwide metabolic disorder that can be debilitating to many if uncontrolled. Biomarkers, such as hemoglobin A1C and glycated albumin, are central to the effort to control diabetes. These each have their own advantages and disadvantages, and there is much ongoing research into development of improved biomarkers and biomarker measurement methods. Continuous glucose monitoring is also widely used to closely monitor diabetes in patients today. Increasingly, however, there has been research focusing on the use of biomarkers in alternative mediums, such as tear fluid or saliva. This review efficiently summarizes the current biomarkers used clinically today, their advantages and disadvantages, and the biomarkers on the horizon that could advance how diabetes is treated in the future.